← All trials
NCT04973345
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2022
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Jul 22, 2021
- Last posted
- Nov 9, 2021
- Enrollment
- 30
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Duke UniversityLead sponsor
- Duke UniversityCollaborator
- Duke UniversitySponsor investigator
- Duke UniversityOverall official - principal investigator
- The EMMES CorporationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.